Your browser is no longer supported. Please, upgrade your browser.
Settings
FHLC Fidelity MSCI Health Care ETF daily Stock Chart
FHLC [NYSE]
Fidelity MSCI Health Care ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.24%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.72%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter5.13%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y11.58%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year14.70%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range38.45 - 47.18 Perf YTD13.73%
Dividend0.55 P/FCF- EPS past 5Y- ROI- 52W High-3.60% Beta-
Dividend %1.21% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low18.28% ATR0.60
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)48.97 Volatility2.14% 1.13%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume3.98 Prev Close44.13
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume222.55K Price45.48
Recom- SMA20-1.10% SMA50-0.08% SMA2007.19% Volume846,032 Change3.06%
Oct-02-18 03:15PM  The 7 Best ETFs of the Third Quarter InvestorPlace
Aug-14-18 06:00AM  Debut of Zero-Fee Funds Puts Fidelity ETFs in the Spotlight Again InvestorPlace
Aug-03-18 03:27PM  12 U.S. Sector ETFs to Play in Case of an Escalating Trade War ETF Trends
Apr-17-18 05:02PM  Tech Advances Could Help Healthcare ETFs Grow ETF Trends
11:49AM  7 Sector ETFs to Own Now InvestorPlace
Apr-03-18 02:59PM  Fidelity Trims Fees on 3 Bond ETFs Benzinga
Mar-12-18 03:54PM  Market Correction May Foreshadow Bullish Run for Stock ETFs ETF Trends
Nov-06-17 09:02AM  The 4 Most Promising ETFs for 2017 (XLF, FHLC) Investopedia
Oct-24-17 04:09PM  What Analysts Recommend for Merck ahead of 3Q17 Earnings Market Realist
Sep-13-17 07:37AM  Must-Know Recent Developments for Gilead Market Realist
Sep-08-17 10:37AM  Inside Mercks Segment-Wise Performance in 2Q17 Market Realist
Aug-31-17 04:36PM  Eli Lilly & Co.s Revenues in 2Q17 Market Realist
Aug-29-17 04:35PM  Bristol-Myers Squibbs Oncology Products in 2Q17 Market Realist
10:39AM  Johnson & Johnsons Consumer Segment in 2Q17 Market Realist
Aug-23-17 07:37AM  How Allergans International Segment Performed in 2Q17 Market Realist
Aug-15-17 07:36AM  Pfizers Declining-Revenue Products in 2Q17 Market Realist
Aug-01-17 10:36AM  Eli Lillys Major Developments in 2Q17 Market Realist
07:41AM  Pfizer on the Street: Analyst Recommendations after 2Q17 Market Realist
Jul-26-17 06:06PM  Analysts Recommendations for Bristol-Myers Squibb in 2Q17 Market Realist
Jul-24-17 10:11AM  Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs Zacks
09:08AM  Johnson & Johnson: Medical Devices in 2Q17 Market Realist
Jul-19-17 11:55AM  J&J Brightens Outlook: Healthcare ETFs in Focus Zacks
Jul-17-17 09:07AM  Johnson & Johnsons 2Q17 Estimates: Medical Devices Market Realist
Jul-10-17 07:39AM  How 2Q17 Is Shaping Up for Pfizer Market Realist
Jul-04-17 09:08AM  Johnson & Johnsons Segment-Wise Performance in 1Q17 Market Realist
Jul-03-17 07:38AM  Merck & Co. Reported 1% Growth in Its 1Q17 Revenues Market Realist
Jun-27-17 07:38AM  Tanezumab Receives FDA Fast Track Designation Market Realist
Jun-20-17 03:36PM  Updates on the Adcetris and Opdivo Combination Market Realist
Jun-19-17 07:36AM  How Eli Lillys Taltz Performed in Clinical Trials Market Realist
Jun-13-17 07:36AM  Akcea Therapeutics Volanesorsen: 1Q17 Performance Market Realist
Jun-01-17 09:09AM  Eli Lilly & Co.s Revenues in 1Q17 Market Realist
May-31-17 09:08AM  How Johnson & Johnsons Consumer Segment Performed in 1Q17 Market Realist
May-23-17 08:14AM  A Close Look at Merck & Co.s Valuation after 1Q17 Earnings Market Realist
May-08-17 07:37AM  Pfizer: Understanding Growth Drivers in 1Q17 Market Realist
May-03-17 07:35AM  Is Eli Lilly & Co.s Valuation Higher Than Its Peers? Market Realist
May-01-17 10:29AM  What Do Analysts Expect from Mercks 1Q17 Earnings? Market Realist
Apr-24-17 10:36AM  Analyst Ratings and Recommendations for Eli Lilly Market Realist
10:06AM  Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1? Zacks
Apr-20-17 03:35PM  Johnson & Johnsons 1Q17 Earnings: Changes in Its Growth Rate Market Realist
Apr-19-17 10:55AM  Lackluster J&J Q1 Pushes Healthcare ETFs Down Zacks
Apr-07-17 11:57AM  Analyzing the Performance of Eli Lilly Stock in 1Q17 Market Realist
Mar-17-17 09:06AM  How BMYs Virology Segment Performed in 2016 Market Realist
09:06AM  How BMYs Virology Segment Performed in 2016
Mar-16-17 01:09PM  A Cost-Efficient Avenue to Health Care Exposure Investopedia
01:09PM  A Cost-Efficient Avenue to Health Care Exposure at Investopedia
Mar-13-17 09:07AM  Johnson & Johnsons Revenue Trends Market Realist
09:07AM  Johnson & Johnsons Revenue Trends
Mar-10-17 08:00AM  Growth Strategy Offers Seven Trump ETFs And 'Black Swan' Protection Investor's Business Daily
08:00AM  Growth Strategy Offers Seven Trump ETFs And 'Black Swan' Protection
Mar-09-17 02:56PM  Rising Rates Not Biggest Driver For Financials ETF.com
Mar-07-17 10:47AM  Are You In The Best Health Care ETF? GOP Moves To Replace ObamaCare Investor's Business Daily
10:47AM  Are You In The Best Health Care ETF? GOP Moves To Replace ObamaCare
Feb-28-17 10:35AM  Pfizers Recent Corporate and Pipeline Developments Market Realist
10:35AM  Pfizers Recent Corporate and Pipeline Developments
Feb-27-17 07:35AM  Merck & Co.s Valuation after Its 4Q16 Earnings Market Realist
07:35AM  Merck & Co.s Valuation after Its 4Q16 Earnings
Feb-24-17 09:06AM  Merck & Co.s Profit Margins for 4Q16 Market Realist
09:06AM  Merck & Co.s Profit Margins for 4Q16
Jan-31-17 08:45AM  Quality and Healthcare: 2 ETFs to Watch on Outsized Volume
Jan-26-17 01:35PM  Changes in Johnson & Johnsons Growth Rate in 4Q16
Jan-25-17 10:20AM  What Can Investors Expect from Eli Lillys 4Q16 Earnings?
Jan-24-17 07:31AM  Why health-care stocks arent moving after President Trumps Obamacare executive order at MarketWatch
Jan-23-17 11:01AM  Can Q4 Earnings Revitalize Healthcare ETFs?
07:36AM  What to Expect from JNJs Consumer Healthcare Segment
Jan-18-17 09:55AM  ETFs in Focus on Robust Q4 UnitedHealth Earnings
Dec-12-16 08:05AM  Johnson & Johnsons Pharmaceuticals Segment in 3Q16
Dec-02-16 10:04AM  Mercks Januvia and Janumet: An Investors Perspective
Nov-30-16 10:04AM  Understanding Pfizers Growth Contributors
Nov-29-16 03:04PM  Allergans US Specialized Therapeutics Segment in 3Q16
Nov-23-16 12:39PM  5 Top-Ranked Sector ETFs Thankful to Trump
Nov-07-16 08:07AM  Pfizers 3Q16 Earnings: An Overview
Nov-02-16 10:06AM  Could Allergans Revenues Show Growth in 3Q16?
08:04AM  Mercks 3Q16 Valuation Cheat Sheet
Oct-24-16 10:28AM  Healthcare ETFs: Gain or Pain Ahead in Q3 Earnings?
08:05AM  How Mercks Blockbuster Drugs Are Impacting Its Revenue
08:04AM  A Look at Johnson & Johnsons Consumer Segment in 3Q16
Oct-21-16 08:06AM  Johnson & Johnsons Growth Rate: How Has It Fluctuated?
Oct-19-16 10:01AM  Buy UnitedHealth ETFs on Upbeat Q3 Earnings
Oct-18-16 10:45AM  J&J Beats on Q3 Earnings: Should You Buy Healthcare ETFs?
Oct-17-16 10:04AM  Johnson & Johnsons Consumer Healthcare Segment: 3Q16 Estimates
Oct-03-16 10:06AM  Recent Corporate and R&D Progress for Merck & Co.
Sep-30-16 10:05AM  Which Products Were Key Contributors to Pfizers Revenue Growth?
Sep-13-16 02:44PM  Previewing Fidelity's Upcoming Low Volatility ETF
Aug-30-16 12:19PM  Whats Johnson & Johnsons Revenue Trend?
10:04AM  Allergans US Specialized Therapeutics Key to Future Growth
08:04AM  Understanding Allergans Revenue Stream in 2Q16
Aug-22-16 12:01PM  ETFs in Focus on Pfizer's Medivation Acquisition
Aug-12-16 05:17PM  Whats Contributing to Mercks Growth?
Aug-08-16 05:09PM  11 Sector ETFs for a Diversified Investment Portfolio
Aug-04-16 04:59PM  Sector ETF Positioning for the Rest of the Year
Aug-02-16 09:08AM  Pfizer Expected to Continue Revenue Growth in 2Q16 Earnings
Jul-28-16 11:05AM  Mercks 2Q16 Estimates: Products with Declining Sales
Jul-27-16 09:12AM  Why Investors Can Expect Operational Growth from Merck in 2Q16
09:08AM  Will Bristol-Myers Squibb See Higher Sales for Eliquis in 2Q16?
Jul-26-16 11:04AM  Whats Johnson & Johnsons Guidance for 2016?
09:07AM  Bristol-Myers Squibbs 2Q16 Estimates: Oncology Segment
08:19AM  Technology & Healthcare: 2 ETFs Trading with Outsized Volume
Jul-21-16 11:28AM  How Were Johnson & Johnsons 2Q16 Earnings Trending?
Jul-19-16 10:08AM  Estimates for Johnson & Johnsons 2Q16 Margins
Jul-12-16 03:58PM  Fidelity Slashes Fees for 11 Sector ETFs
The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care Index. The fund is non-diversified.